Global Cotinine Screening Devices Market Size study, By Device Type, By Sample Type, By End-User, and Regional Forecasts 2022-2028
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
発行: Bizwit Research & Consulting LLP
List of figures
Global Cotinine Screening Devices Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Cotinine Screening Devices refers to testing equipment utilized to measure the cotinine in human body. Cotinine is an alkaloid substance, formed in the human body after the consumption of nicotine. Cotinine is a biomarker indicating tobacco consumption. Cotinine is used for testing substance abuse in people as it stays in the human body for approximately 8 to 10 days. The growing prevalence of pulmonary disease and increasing number of smoking cessation campaigns as well as rising adoption of Cotinine Screening from corporates are factors that are accelerating the global market demand. For instance, according to World Health Organization (WHO) estimates - as of 2019, Chronic obstructive pulmonary disease (COPD) estimated as the third leading cause of death worldwide, causing 3.23 million deaths. Nearly 90% of COPD deaths in individuals under 70 years of age occurred in low- and middle-income countries (LMIC). Furthermore, the increasing adoption of nicotine testing from corporates would influence the growth of Cotinine Screening Devices. For instance, in January 2020, Arizona, USA based truck, trailer, and self-storage rental company U-Haul announced a nicotine-free hiring policy. This new policy would be effective in 21 states on February 1st , 2020. Also, growing incidence of lung cancer and surging healthcare infrastructure in emerging markets are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, low reimbursement rate for tobacco abuse testing impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Cotinine Screening Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing utilization of cotinine screening and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing adoption of nicotine screening and favorable government initiatives to curb smoking in the region, would create lucrative growth prospects for the global Cotinine Screening Devices Market across the Asia Pacific region.
Major market players included in this report are:
Jant Pharmacal Corporation
Sinocare Inc., (PTS Diagnostics)
Hangzhou Clongene Biotech Co.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device Type
By Sample Type
Workplace Screening Centers
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Cotinine Screening Devices Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers